Xechem International Inc. (fka XKEM)

[Eli's Gone]

and I find the very next paragraph after your quote interesting as well...

Meanwhile, Xechem is seeking approval to market the sickle cell treatment in the United States and Europe. “A company that is centered on a niche drug isn’t necessarily a bad thing,” says Andersen. “They might be able to charge thousands of dollars for treatment if the drug is approved in the U.S. or Europe.”